Stephanie Smith Fostvedt, | |
2519 N Hillcrest Pkwy, Suite201, Altoona, WI 54720-2584 | |
(715) 832-8432 | |
(715) 832-5007 |
Full Name | Stephanie Smith Fostvedt |
---|---|
Gender | Female |
Speciality | Counselor - Mental Health |
Location | 2519 N Hillcrest Pkwy, Altoona, Wisconsin |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1467888727 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101YM0800X | Counselor - Mental Health | 1704-226 (Wisconsin) | Primary |
Mailing Address | Practice Location Address |
---|---|
Stephanie Smith Fostvedt, 2519 N Hillcrest Parkway, Suite201, Altoona, WI 54720-2588 Ph: (715) 832-8432 | Stephanie Smith Fostvedt, 2519 N Hillcrest Pkwy, Suite201, Altoona, WI 54720-2584 Ph: (715) 832-8432 |
News Archive
PharmaMar, a biopharmaceutical company owned by Grupo Zeltia (ZEL.MC), presented six new trials with marine-based anti-tumor drugs Yondelis(R), Zalypsis(R) and Irvalec(R) at the American Association for Cancer Research's (AACR) 101st Annual Meeting, held in Washington, D.C. from April 17-21.
Reports of adverse events, including death, from silicone injections for cosmetic purposes have been increasing in both medical and consumer literature. In studies presented at CHEST 2011, the 77th annual meeting of the American College of Chest Physicians (ACCP), in Honolulu, Hawaii, researchers from Louisiana State University Health Sciences Center in New Orleans, Louisiana; Henry Ford Hospital in Detroit, Michigan; and Olive View-UCLA Medical Center in Sylmar, California all reported cases of near-lethal and lethal silicone use.
A new Skin Cancer Research Fund Laboratory has been set up in Bristol to study cancer cells collected from skin cancer patients attending Frenchay Hospital. It is hoped the new facility will speed up research into treatments for malignant melanoma - the most deadly form of skin cancer. The new laboratory at the Microvascular Research Laboratories at the University of Bristol will be officially opened today (Tuesday August 22nd) by the director of the Skin Cancer Research Fund, Mr Paul Townsend.
Neurocrine Biosciences, Inc. announced today that NBI-77860, a proprietary corticotropin releasing factor 1 (CRF) receptor antagonist, has been granted orphan drug status by the United States Food and Drug Administration (FDA) for the treatment of congenital adrenal hyperplasia (CAH) a disease that affects approximately 20,000-30,000 people in the United States.
› Verified 3 days ago
Chastity Drake, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 2519 N Hillcrest Pkwy, Ste 201, Altoona, WI 54720 Phone: 715-832-8432 Fax: 715-832-5007 | |
Denise Amrhein-sprunk, M.S. LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 2519 N Hillcrest Pkwy Ste 201, Altoona, WI 54720 Phone: 715-832-8432 | |
Lindsey L Field, Counselor Medicare: Medicare Enrolled Practice Location: 3119 Woodman Dr, Altoona, WI 54720 Phone: 888-277-3832 |